1. Current Approaches in Cardiac Repair: Somatic and Stem Cell Exosomes
    Selcen Ari Yuka et al, 2023, Current Treatment Options in Cardiovascular Medicine CrossRef
  2. Extracellular vesicles in atherosclerosis and vascular calcification: the versatile non-coding RNAs from endothelial cells and vascular smooth muscle cells
    Fengyi Yu et al, 2023, Frontiers in Medicine CrossRef
  3. Advances in the study of exosomes in cardiovascular diseases
    Zhaobo Zhang et al, 2023, Journal of Advanced Research CrossRef
  4. Maresin 1 enhances osteogenic potential of mesenchymal stem cells by modulating macrophage peroxisome proliferator-activated receptor-γ-mediated inflammation resolution
    Dongdong Yao et al, 2022, Biomaterials Advances CrossRef
  5. Targeting PPARs for therapy of atherosclerosis: A review
    Miao Miao et al, 2023, International Journal of Biological Macromolecules CrossRef
  6. The therapeutic efficacy and clinical translation of mesenchymal stem cell-derived exosomes in cardiovascular diseases
    Huan Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  7. Macrophage Gpx4 deficiency aggravates foam cell formation by regulating the expression of scavenger receptors, ABCA1, and ABCG1
    Jingquan Zhou et al, 2023, Cell Biology International CrossRef
  8. Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation
    Mangala Hegde et al, 2023, Cytokine & Growth Factor Reviews CrossRef
  9. Bone marrow mesenchymal stem cells-derived exosomal lncRNA GAS5 mitigates heart failure by inhibiting UL3/Hippo pathway-mediated ferroptosis
    Yu Ren et al, 2024, European Journal of Medical Research CrossRef
  10. Mesenchymal Stem Cell-Derived Long Noncoding RNAs in Cardiac Injury and Repair
    Talan Tran et al, 2023, Cells CrossRef
  11. Mesenchymal stem cell-derived extracellular vesicles relieve endothelial cell senescence via recovering CTRP9 upon repressing miR-674-5p in atherosclerosis
    Min Zeng et al, 2024, Regenerative Therapy CrossRef
  12. LncRNA DANCR promotes macrophage lipid accumulation through modulation of membrane cholesterol transporters
    Guo-Jun Zhao et al, 2024, Aging CrossRef
  13. Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases
    Chenglong Wang et al, 2023, Asian Journal of Pharmaceutical Sciences CrossRef
  14. Role of Macrophage lncRNAs in Mediating Inflammatory Processes in Atherosclerosis and Sepsis
    Hyeung-Seob Shin et al, 2023, Biomedicines CrossRef
  15. Stem Cell Therapy against Ischemic Heart Disease
    I-Ting Tsai et al, 2024, International Journal of Molecular Sciences CrossRef
  16. Research progress of signaling pathways of the natural substances intervene dyslipidemia (Review)
    Ningning Cao et al, 2022, Experimental and Therapeutic Medicine CrossRef
  17. Perspective Chapter: Clinical Application of Exosome Components
    Mengyuan Hou et al, 2023, Exosomes - Recent Advances From Bench to Bedside CrossRef
  18. Mesenchymal stem cell-derived extracellular vesicles for human diseases
    Xiaofang Zhang et al, 2024, Extracellular Vesicles and Circulating Nucleic Acids CrossRef
  19. Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy
    Yanhong Pan et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  20. Long term exercise-derived exosomal LncRNA CRNDE mitigates myocardial infarction injury through miR-489-3p/Nrf2 signaling axis
    Wujun Chen et al, 2024, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
  21. Exosomes based strategies for cardiovascular diseases: Opportunities and challenges
    Hang Li et al, 2024, Biomaterials CrossRef